-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Publication|Articles|October 16, 2026

Supplements and Featured Publications

  • Continuous Glucose Monitoring for Adults With Type 2 Diabetes Not Treated With Insulin: Evidence to Inform Managed Care Coverage and Access Decisions

Continuous Glucose Monitoring for Adults With Type 2 Diabetes Not Treated With Insulin: Evidence to Inform Managed Care Coverage and Access Decisions

This clinical brief was sponsored by Dexcom, Inc.

The objective of this clinical brief is to help managed care decision makers evaluate whether coverage policies for continuous glucose monitoring (CGM) should evolve for adults with type 2 diabetes (T2D) who are not treated with insulin. The brief focuses on the evidence most relevant to payers, pharmacy benefit managers, policy makers, and health system leaders: updated clinical guidance, randomized and real-world outcomes, health care resource utilization (HCRU), quality measurement, and remaining access gaps.

Related to this article